Overview

Evaluating the Safety and Efficacy of Topical Sirolimus 0.2% to Treat Acanthosis Nigricans

Status:
RECRUITING
Trial end date:
2025-07-18
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate the safety and efficacy of Sirolimus 0.2% topical gel for patients with Acanthosis Nigricans
Phase:
PHASE2
Details
Lead Sponsor:
Narrows Institute for Biomedical Research
Collaborator:
Nobelpharma